Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 91 AL 105

Emerging Promise of Immunotherapy for Alzheimer's Disease: A New Hope for the Development of Alzheimer's Vaccine

Kabir MT, Uddin MS, Mathew B, Das PK, Perveen A, Ashraf GM.

Curr Top Med Chem. 2020;20(13):1214-1234. doi: 10.2174/1568026620666200422105156.

A systematic review on anti-Alzheimer's disease activity of prescription Kangen-karyu

Paudel P, Park CH, Jung HA, Yokozawa T, Choi JS.

Drug Discov Ther. 2020 May 6;14(2):61-66. doi: 10.5582/ddt.2020.03013. Epub 2020 Apr 24.

Verum- versus Sham-Acupuncture on Alzheimer's Disease (AD) in Animal Models: A Preclinical Systematic Review and Meta-Analysis

Zhao FY, Fu QQ, Zheng Z, Lao LX, Song HL, Shi Z.

Biomed Res Int. 2020 Mar 31;2020:5901573. doi: 10.1155/2020/5901573. eCollection 2020.

Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia

Fink HA, Linskens EJ, MacDonald R, Silverman PC, McCarten JR, Talley KMC, Forte ML, Desai PJ, Nelson VA, Miller MA, Hemmy LS, Brasure M, Taylor BC, Ng W, Ouellette JM, Sheets KM, Wilt TJ, Butler M.

Ann Intern Med. 2020 May 19;172(10):656-668. doi: 10.7326/M19-3887. Epub 2020 Apr 28.

Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease

Ghosh S, Durgvanshi S, Agarwal S, Raghunath M, Sinha JK.

Curr Neuropharmacol. 2020;18(9):883-903. doi: 10.2174/1570159X18666200429011823.

Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease

Uddin MS, Kabir MT, Mamun AA, Barreto GE, Rashid M, Perveen A, Ashraf GM.

Int Immunopharmacol. 2020 Jul;84:106479. doi: 10.1016/j.intimp.2020.106479. Epub 2020 Apr 27.

Tau immunotherapies: Lessons learned, current status and future considerations

Sandusky-Beltran LA, Sigurdsson EM.

Neuropharmacology. 2020 Sep 15;175:108104. doi: 10.1016/j.neuropharm.2020.108104. Epub 2020 Apr 28.

The current landscape in Alzheimer's disease research and drug discovery

Devenish SRA.

Drug Discov Today. 2020 Jun;25(6):943-945. doi: 10.1016/j.drudis.2020.04.002. Epub 2020 Apr 28.

Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease

Joshi A, Wang DH, Watterson S, McClean PL, Behera CK, Sharp T, Wong-Lin K.

Neuropharmacology. 2020 Sep 1;174:108118. doi: 10.1016/j.neuropharm.2020.108118. Epub 2020 May 4.

Photobiomodulation for Alzheimer's Disease: Translating Basic Research to Clinical Application

Enengl J, Hamblin MR, Dungel P.

J Alzheimers Dis. 2020;75(4):1073-1082. doi: 10.3233/JAD-191210.

A Systematic Review of Current Progresses in the Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer's Disease

Ghaffari M, Sanadgol N, Abdollahi M.

Mini Rev Med Chem. 2020;20(15):1499-1517. doi: 10.2174/1389557520666200513122357.

Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist

Ribaudo G, Ongaro A, Zagotto G, Memo M, Gianoncelli A.

ACS Chem Neurosci. 2020 Jun 17;11(12):1726-1739. doi: 10.1021/acschemneuro.0c00244. Epub 2020 May 28.

Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case report

Mimura Y, Kurose S, Takata T, Tabuchi H, Mimura M, Funayama M.

BMC Neurol. 2020 May 13;20(1):183. doi: 10.1186/s12883-020-01769-2.

Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study

Novak G, Streffer JR, Timmers M, Henley D, Brashear HR, Bogert J, Russu A, Janssens L, Tesseur I, Tritsmans L, Van Nueten L, Engelborghs S.

Alzheimers Res Ther. 2020 May 14;12(1):58. doi: 10.1186/s13195-020-00614-5.

Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing

Uddin MS, Kabir MT, Jeandet P, Mathew B, Ashraf GM, Perveen A, Bin-Jumah MN, Mousa SA, Abdel-Daim MM.

Oxid Med Cell Longev. 2020 Apr 29;2020:7039138. doi: 10.1155/2020/7039138. eCollection 2020.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias